Last reviewed · How we verify
IBU group
At a glance
| Generic name | IBU group |
|---|---|
| Also known as | Ibuprofen (IBU) |
| Sponsor | Fundació Institut Germans Trias i Pujol |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Osteoarthritis
- Arthralgia
- Hypertension
- Diarrhoea
- Upper respiratory tract infection
- Back pain
- Bronchitis
- Pain in extremity
- Nausea
- Urinary tract infection
- Gastrooesophageal reflux disease
- Dyspepsia
Key clinical trials
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis (NA)
- Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement (PHASE2)
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- "Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy" (PHASE4)
- Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery (NA)
- Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial (PHASE4)
- Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |